Skip to main content

Table 4 Comparisons of NT-proBNP levels according to the occurrence of cardiac dysfunctions during the intensive care unit course

From: N-terminal pro-brain natriuretic peptide as an early prognostic factor in cancer patients developing septic shock

 

RVD (n = 17)

LVSD (n = 18)

LVDD (n = 18)

NCD (n = 11)

NT-proBNP in pg/ml on day 1

6,138 (3,530–16,458)

6,214 (3,721–30,409)

9,001 (4,000–33,167)

4,220 (488–17,371)

NT-proBNP in pg/ml on day 2

7,685 (3,965–23,433)a

9,083 (3,860–22,784)a

11,254 (4,067–37,804)a

914 (447–12,545)

  1. ap < 0.05 compared to the no cardiac dysfunction (NCD) group. Data are expressed as median (25th–75th percentiles). The number of patients in whom NT-proBNP was measured on day 2 was the same as on day 1 (no death on day 1). LVDD, left ventricular diastolic dysfunction; LVSD, left ventricular systolic dysfunction; NT-proBNP, N-terminal pro-brain natriuretic peptide; RVD, right ventricular dysfunction.
Back to article page

Critical Care

ISSN: 1364-8535